Cargando…
Investigation of ovarian cancer associated sialylation changes in N-linked glycopeptides by quantitative proteomics
BACKGROUND: In approximately 80% of patients, ovarian cancer is diagnosed when the patient is already in the advanced stages of the disease. CA125 is currently used as the marker for ovarian cancer; however, it lacks specificity and sensitivity for detecting early stage disease. There is a critical...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488482/ https://www.ncbi.nlm.nih.gov/pubmed/22856521 http://dx.doi.org/10.1186/1559-0275-9-10 |